Profiel
Nancy Sacco is a former Head of Clinical Development at AnaptysBio, Inc. and a former Vice President and Head of Clinical Development at Xentria, Inc. She also served as the Chief Development Officer at Hexima Ltd.
in 2021-2022.
Sacco holds a doctorate degree from West Virginia University School of Medicine.
Eerdere bekende functies van Nancy Sacco
| Bedrijven | Functie | Einde |
|---|---|---|
| HEXIMA LIMITED | Corporate Officer/Principal | 15-10-2022 |
Xentria, Inc.
 Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Chief Tech/Sci/R&D Officer | - |
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Nancy Sacco
| West Virginia University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| HEXIMA LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Health Technology |
